Elutia Inc. (ELUT)
- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $0.77
- As of
Kresmion compiles this page from ELUT's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
ELUTIA INC. (ELUT): 2 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-21.
See the full ELUT dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for ELUT on one page. Preview it with sample data, then open it live with a free account.
Preview the ELUT dossierActive signals for ELUT
- mediumEARNINGS_MISS
Q2-2026: Missed consensus by 11.1%, EPS $-0.17 vs $-0.153 estimate
- highINSTITUTIONAL_SURGE
RENAISSANCE TECHNOLOGIES LLC added +144% to ELUT (2026Q2)
- mediumEARNINGS_MISS
Q1-2026: Missed consensus by 11.1% - EPS $-0.17 vs $-0.153 estimate
- mediumEARNINGS_MISS
Q2-2025: Missed consensus by 32.6% - EPS $-0.23 vs $-0.1734 estimate
- mediumEARNINGS_BEAT
Q3-2025: Beat consensus by 43.1% - EPS $-0.09 vs $-0.1581 estimate
FREE, NO ACCOUNT
Every signal on ELUT, as it fires
You are seeing 5 of 7 signals recorded on ELUT since 2026-06-10.
The five above landed across 4 days. The other 2 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in ELUT (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 05479K106 · 2026Q2 | $198K | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 05479K106 · 2026Q2 | $121K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, ELUT
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
ELUT against its peers
ELUT's operating margin of -218.9% ranks in the 48th percentile of 23 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | ELUT | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 12.3M USD | 13.0M USD | 48 | 23 |
| Revenue YoY | n/a | 15.4% | n/a | 5 |
| Gross margin | 53.7% | 57.6% | 50 | 20 |
| Operating margin | -218.9% | -141.1% | 48 | 23 |
| Net margin | 434.2% | -121.0% | 94 | 23 |
| Return on equity | 192.9% | -88.4% | 93 | 21 |
| P / E | 0.9x | n/a | n/a | 2 |
| 1 year | -14.6% | -39.9% | 82 | 18 |
Peers (24): CVRX, NSYS, ARAY, QTI, ITOC, NSPR, NNOX, FOFA, PETV, RPID, XTNT, SRTS, BDMD, SNWV, PAVM, TELA, COCH, MDAI, MODD, RDGL, POSC, MDNC, GTHP, LFWD. Left out: TLTFF (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (ELUT: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow ELUT on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to ELUT for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.